PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $159,008 | +258.3% | 9,170 | +274.4% | 0.01% | +400.0% |
Q2 2023 | $44,376 | +260935.3% | 2,449 | +271.6% | 0.00% | 0.0% |
Q1 2023 | $17 | -46.9% | 659 | -59.7% | 0.00% | 0.0% |
Q4 2022 | $32 | -100.0% | 1,635 | -69.8% | 0.00% | -50.0% |
Q3 2022 | $113,000 | +352.0% | 5,412 | +73.3% | 0.00% | +100.0% |
Q2 2022 | $25,000 | +56.2% | 3,123 | +37.6% | 0.00% | – |
Q1 2022 | $16,000 | -27.3% | 2,270 | +39.3% | 0.00% | – |
Q4 2021 | $22,000 | +100.0% | 1,630 | +130.6% | 0.00% | – |
Q3 2021 | $11,000 | -76.1% | 707 | -55.6% | 0.00% | -100.0% |
Q2 2021 | $46,000 | -24.6% | 1,591 | +2.2% | 0.00% | 0.0% |
Q1 2021 | $61,000 | +110.3% | 1,557 | +24.4% | 0.00% | 0.0% |
Q4 2020 | $29,000 | -71.0% | 1,252 | -71.7% | 0.00% | 0.0% |
Q3 2020 | $100,000 | – | 4,425 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |